Epigenetics Drugs And Diagnostic Technologies Market Size And Share

  • Report Code : TIPRE00005164
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse des parts de marché des médicaments épigénétiques et des technologies de diagnostic d'ici 2025-2031

Buy Now

Epigenetics Drugs and Diagnostic Technologies Market Report Analysis

Epigenetics Drugs and Diagnostic Technologies Market

  • CAGR (2025 - 2031)
    14%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc
  • Eisai Co. Ltd
  • Novartis AG
  • Illumina, Inc
  • QIAGEN
  • Abcam PLC
  • Merck KGaA.
  • Genome Profiling, LLC

Regional Overview

  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique

Market Segmentation

By Produits
  • réactifs
  • kits
  • instruments
  • enzymes
  • services
By Technologie
  • méthylation de l'ADN
  • méthylation des histones
  • acétylation des histones
  • grands ARN non codants
  • modification des microARN
  • structures de la chromatine
By Type
  • inhibiteurs de l'histone désacétylase
  • inhibiteurs de l'ADN méthyltransférase
By Application
  • oncologie
  • non-oncologie